ロード中...
Hyperoside Attenuates Bleomycin-Induced Pulmonary Fibrosis Development in Mice
Idiopathic pulmonary fibrosis (IPF) is a progressive, lethal, and chronic lung disease. There are no effective drug therapies for IPF. Hyperoside, a flavonoid glycoside, has been proven to have anti-inflammatory, anti-fibrosis, antioxidant, and anti-cancer effects. The aim of this study was to explo...
保存先:
| 出版年: | Front Pharmacol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7642689/ https://ncbi.nlm.nih.gov/pubmed/33192501 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.550955 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|